A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation

NCT ID: NCT07250581

Last Updated: 2025-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to explore the indications and application scope of spinal endoscopy combined with annulus fibrosus repair technology, with a focus on verifying the effectiveness of annulus fibrosus suture technology and evaluating its safety, so as to further support the promotion of annulus fibrosus repair technology in patients with lumbar disc herniation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Background Lumbar Disc Herniation (LDH) is a significant clinical and public health issue, particularly due to its high incidence and impact on working-age populations. It is a leading cause of non-fatal health loss globally. While conservative management is first-line, surgery is indicated for refractory cases. Among surgical options, endoscopic discectomy has emerged as a superior minimally invasive technique, offering advantages like minimal trauma, rapid recovery, and preserved spinal stability compared to open surgery or fusion.

However, a key limitation of standard endoscopic discectomy is the residual defect in the annulus fibrosus (AF) after nucleus pulposus removal. This defect is a significant risk factor for postoperative recurrence, as residual disc material can re-herniate. Larger defects (≥6mm) are associated with significantly higher recurrence and reoperation rates. Annulus repair techniques, initially attempted in open surgery with limited success due to extensive tissue disruption, hold renewed promise in the minimally invasive endoscopic context. The recent development of dedicated endoscopic AF suture devices in China enables precise repair through the endoscope, potentially reducing recurrence and postoperative neural complications by restoring AF integrity, minimizing scar adhesion, and containing inflammatory mediators.

Preliminary clinical application of this AF suture technique in over 12,000 cases suggests it adds only minimal time (\~8 minutes) to the procedure while offering significant potential benefits. This study aims to rigorously evaluate the safety and efficacy of endoscopic discectomy combined with AF repair versus discectomy alone through a prospective, multicenter, randomized controlled trial (RCT).
2. Study Objectives and Significance Primary Objectives:To evaluate the efficacy of AF repair in reducing the postoperative recurrence rate of LDH.To assess the safety of AF repair by comparing perioperative complications and early postoperative pain exacerbation between the suture and control groups.

Significance:This study will provide high-quality, multicenter RCT data to clarify the indications, technical nuances, clinical outcomes, and recurrence prevention effect of endoscopic AF suture. The findings will support the standardization and scientific application of this promising technology, offering valuable evidence for clinicians and patients in selecting optimal treatment strategies, particularly for young and active patients seeking rapid recovery and long-term durability.
3. Study Design and Methods Study Type: Prospective, multicenter, randomized controlled trial. Study Population:Participants: Patients aged 12-65 years diagnosed with symptomatic LDH from multiple participating centers.

Inclusion Criteria:

Age 12-65, any gender. Confirmed diagnosis of LDH. Non-calcified herniation type. Preoperative MRI shows Pfirrmann grade I-II disc degeneration. Failure of ≥6 months conservative treatment with significant impact on quality of life.

Willing and able to provide informed consent and comply with long-term follow-up.

Exclusion Criteria:

Concomitant lumbar spondylolisthesis, instability, or other significant spinal pathologies.

Previous lumbar spine surgery. Major systemic diseases contraindicating surgery. Conditions potentially affecting healing (e.g., malnutrition, bone metabolic diseases, autoimmune diseases).

Inability to adhere to follow-up schedule.

Intervention and Groups:Eligible patients will be randomly assigned to one of two groups:

Intervention Group: Endoscopic Discectomy + Annulus Fibrosus Repair. Control Group: Endoscopic Discectomy alone. Randomization: Randomization will be performed using PASS 11.0 generated random sequence after informed consent and baseline assessment, based on order of enrollment.

Outcome Measures:

Primary Outcomes:

Surgical success rate (successful completion of AF suture). Recurrence rate (re-herniation at the operated level) at short-term and long-term follow-up.

Postoperative efficacy: assessed by Visual Analog Scale (VAS) for back/leg pain, Japanese Orthopaedic Association (JOA) score, and Oswestry Disability Index (ODI).

Reoperation rate. Postoperative inflammatory markers (e.g., CRP, Procalcitonin).

Secondary Outcomes:

Incidence of nerve injury (sensory/motor). Incidence of bleeding/hematoma. Overall complication rate (e.g., infection, dural tear). Postoperative infection rate.

Data Collection and Follow-up:

Data collected includes demographic details, perioperative parameters (surgical level, time, blood loss, hospital stay), clinical scores (VAS, ODI, JOA), imaging data (herniation size, AF defect size, spinal canal area), and laboratory tests. Follow-up assessments are scheduled at 1, 3, 6, and 12 months postoperatively. Imaging follow-up includes MRI at 3 months, CT at 6 months, and both CT/MRI at 12 months.

Statistical Analysis:

Data will be managed using an Electronic Data Capture (EDC) system and analyzed with SPSS 25.0. Appropriate descriptive statistics will be used. Group comparisons for continuous variables will use t-tests or Mann-Whitney U tests, and chi-square tests for categorical variables. Repeated Measures ANOVA will analyze longitudinal data. Missing data will be handled with appropriate imputation methods and sensitivity analysis. A significance level of α=0.05 (two-sided) will be used.

Sample Size Calculation:

Based on an assumed recurrence rate of 5% in the control group and 2.4% in the intervention group, with α=0.05 and 90% power, a sample size of 224 is required. Accounting for a potential 20% dropout rate, the total target sample size is 300 patients. The lead center (Qingdao University Affiliated Hospital) will contribute approximately 100 patients.

Participating Centers (Multicenter):

The study involves one primary center and nine participating centers across China, each led by a principal investigator:

Primary Center: The Affiliated Hospital of Qingdao University. Participating Centers: Include Qilu Hospital of Shandong University, Shandong Provincial Hospital, Peking Union Medical College Hospital, The First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Wenzhou Medical University, The Third Xiangya Hospital of Central South University, The Second Affiliated Hospital of Xi'an Jiaotong University, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, among others.

Ethics and Quality Control:

The protocol will be submitted for ethical approval at each center. Investigators will receive standardized training on the AF suture technique and data management procedures. Data integrity, accuracy, and confidentiality will be ensured through rigorous quality control measures, including training, data validation rules, double data entry checks, and secure handling of identifiable information.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Intervertebral Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Annulus fibrosus repair

Annulus fibrosus repair, Suture the incision of the annulus fibrosus

Group Type EXPERIMENTAL

Repair of the annulus fibrosus

Intervention Type PROCEDURE

Suture the incision of the annulus fibrosus

Non-annulus fibrosus repair

Non-annulus fibrosus repair, Do not suture the incision of the annulus fibrosus

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Repair of the annulus fibrosus

Suture the incision of the annulus fibrosus

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: 12 years old to 65 years old, gender not limited;
2. Diagnosed with Lumbar disc herniation;
3. Preoperative intervertebral disc MRI Pfirrmann grade I - II;
4. Conservative treatment is ineffective, and the symptoms significantly affect life;
5. Be able to cooperate with long-term follow-up and sign the informed consent form.

Exclusion Criteria

1. Accompanied by lumbar spondylolisthesis, lumbar instability and other lumbar diseases, etc.
2. Previous history of lumbar spine surgery;
3. Those who have other major physical diseases and are unable to tolerate surgery;
4. Diseases such as malnutrition, abnormal bone metabolism, and autoimmune diseases that may affect the postoperative development process;
5. Unable to accept regular follow-up visitors
Minimum Eligible Age

12 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Qilu Hospital of Shandong University

OTHER

Sponsor Role collaborator

Shandong Provincial Hospital

OTHER_GOV

Sponsor Role collaborator

Qianfoshan Hospital

OTHER

Sponsor Role collaborator

Peking Union Medical College Hospital

OTHER

Sponsor Role collaborator

First Affiliated Hospital of Harbin Medical University

OTHER

Sponsor Role collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

Sponsor Role collaborator

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

Sponsor Role collaborator

The Third Xiangya Hospital of Central South University

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

Sponsor Role collaborator

The Affiliated Hospital of Qingdao University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

maxuexiao

Endoscopic Discectomy with Repair of Annulus Fibrosus versus Discectomy Alone for Lumber Disc Herniation:A prospective Multicenter Randomized Controlled Trial

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Affiliated Hospital of Qingdao University

Qingdao, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

xuexiao Ma

Role: CONTACT

053282913568

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xuexiao Ma

Role: primary

+86-0532-82913568

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QYFYEC2025-136

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Paraspinal Muscle Remodeling
NCT03753711 COMPLETED NA
Ambulatory Lumbar Disk Surgery
NCT02807194 COMPLETED NA